#24DaysOfDementiaResearch – The MK8931 Trial
This study, and many others, are available on ‘Join dementia research’ – a new online service that allows volunteers to discover and participate in dementia research studies around the country.
Aims of the Study
This study aims to test a new medication (MK8931) in the treatment of Mild Cognitive Impairment.
This medication acts to reduce the levels of a brain protein called amyloid, which is known to build up in excessive amounts in those with, or at risk of, Alzheimer’s disease.
The study will also measure how well people are able to tolerate the medication, and monitors for any side effects.
Volunteers are sought who are between 50 and 85, with mild memory problems or Mild Cognitive Impairment.
They will need to have a study ‘partner’ – a close friend or relative who can accompany the volunteer throughout the research.
Let us know!
We always want to hear from people taking part in ‘Join dementia research’ studies!
Do you find it rewarding to take part in research? What would you say to others considering joining dementia research?